For the very best in pediatric care for lungs and breathing issues, the Division of Pediatric Pulmonology at C.S. Mott Children’s Hospital, part of the University of Michigan Health System, offers top-level programs, nationally recognized services and new initiatives to improve the respiratory health of all children.
Highlights of our division include:
- A nationally recognized Cystic Fibrosis Center
- One of the largest ventilator rehabilitation programs in the country
- A cutting-edge pulmonary function laboratory for infants and children
- A multidisciplinary pediatric sleep apnea program
- Flexible bronchoscopy (viewing the inside of your airway)
- Special services for patients with asthma, apnea, bronchopulmonary dysplasia (lung disorder that affects infants), chronic lung disease and respiratory insufficiency
Our Children's Asthma Wellness Program assists primary-care providers with difficult cases of pediatric asthma. We provide intensive education for families plus case management to asthmatic children three years and older who have had at least two emergency department visits for asthma and/or one hospitalization. It is the only such program in the state to have received Disease Management Certification from the Joint Commission, and is 1 of only 4 programs in the nation to receive certification in Asthma-Pediatrics.
The Cystic Fibrosis Center is the largest program in the state of Michigan. Our research improves our knowledge of cystic fibrosis and provides better ways to treat it. As a result, our patients' expected life spans have steadily increased expectation. So many are now living into adulthood, we created an adult program to support patients over 21 years of age.
Our Pulmonary Function Laboratory offers a range of tests from a staff of experienced respiratory therapists who put both patients and parents quickly at ease with their commitment to patient care. The testing includes pulmonary function testing for infants and children, asthma testing, spirometry (measures lungs for conditions that affect breathing), infant pulmonary function testing, exercise testing, quantitative sweat testing (for cystic fibrosis) and modified sleep studies.
The Comprehensive Apnea and Bronchopulmonary Dysplasia Program works in consultation with general pediatricians to improve the outcomes of infants with developmental respiratory problems such as apnea and bronchopulmonary dysplasia. With the use of newer treatments, including prenatal steroids and exogenous surfactant, smaller, more premature infants are now surviving.